The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
Abstract
Immunosuppressive therapy can produce hematologic improvement in a large proportion of patients with severe aplastic anemia. Antithymocyte globulin (ATG) is the current treatment of choice for patients who do not have histocompatible sibling donors or who are otherwise inegligible for allogeneic bone marrow transplantation. About 50% of patients respond to an initial course of ATG, and many nonresponders can be salvaged by subsequent treatment with cyclosporine (CsA). To determine whether simultaneous administration of these agents could further improve response rates, we enrolled 55 patients in a therapeutic trial of 4 days of ATG and 6 months of CsA. Among the 51 patients who had not received previous courses of ATG or CsA, 67% had responded by 3 months, and 78% had responded by 1 year (response was defined as an increase in peripheral blood counts sufficient that a patient no longer met the criteria for severe disease). There was a high incidence of relapse (36% actuarial risk at 2 years), but most relapsed patients responded to additional courses of immunosuppression, and relapse was not associated with a significant survival disadvantage. Evolution to myelodysplastic syndromes and acute leukemia was rare (1 of 51 patients), but the later appearance of paroxysmal nocturnal hemoglobinuria was more common (5 of 51 patients). Actuarial survival was 86% at 1 year and 72% at 2 years. These data support the use of a combination immunosuppressive regimen containing both ATG and CsA as first-line therapy for severe aplastic anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malignant Tumors Occurring after Treatment of Aplastic Anemia
Socié, G., Henry-Amar, M., Bacigalupo, A. P., Hows, J., Tichelli, A., Ljungman, P. T., McCann, S. R., Frickhofen, N., Veer-Korthof, E. T. V., & Gluckman, É. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291603 · Cited by 458
Frickhofen, N., Kaltwasser, J. P., Schrezenmeier, H., Raghavachar, A., Vogt, H. G., Herrmann, F., Freund, M., Meusers, P., Salama, A., Heimpel, H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241901 · Cited by 415
Bacigalupo, A., Hows, J., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M. T., Congiu, M., De Planque, M. M., Ernst, P., McCann, S., et al. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02460.x · Cited by 385
Late haematological complications in severe aplastic anaemia
Tichelli, A., Gratwohl, A. A., Würsch, A., Nissen, C., & SPECK, B. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02382.x · Cited by 273
The Jackknife, the Bootstrap and Other Resampling Plans.
Burnham, K. P., & Efron, B. (1983) · Biometrics · doi:10.2307/2531123 · Cited by 258
A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases
Young, N. S., Griffith, P. M., Brittain, E., Elfenbein, G. J., Gardner, F. H., Huang, A. T., Harmon, D. C., Hewlett, J. S., Fay, J., & Mangan, K. F. (1988) · Blood · doi:10.1182/blood.v72.6.1861.1861 · Cited by 126
Self-citationBacigalupo, A. P., Chaple, M., Hows, J., Lint, M. T. V., McCann, S. R., Milligan, D. W., Chessells, J. M., Goldstone, A. H., Ottolander, J., Veer, E. T. V., et al. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04645.x · Cited by 111
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia
Leonard, E. M., Raefsky, E. L., Griffith, P. M., Kimball, J., Nienhuis, A. W., & Young, N. S. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb07695.x · Cited by 89
Self-citationSchubert, J. E. A., Vogt, H., Zielinska‐Skowronek, M., et al. (1994) · Blood · doi:10.1182/blood.v83.8.2323.2323 · Cited by 86
Champlin, R., Ho, W. G., Sa, F., Winston, D. J., Lenarsky, C., & Rp, G. (1985) · Blood · doi:10.1182/blood.v66.1.184.184 · Cited by 77
Cited by
Modulating the stem cell niche for tissue regeneration
Lane, S. W., Williams, D. A., & Watt, F. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2978 · Cited by 615
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
Townsley, D. M., Scheinberg, P., Winkler, T., Desmond, R., Dumitriu, B., Rios, O., Weinstein, B., Valdez, J., Lotter, J., Feng, X., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613878 · Cited by 562
Self-citationThe Pathophysiology of Acquired Aplastic Anemia
Young, N. S., & Maciejewski, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361906 · Cited by 505
Self-citationHorse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
Scheinberg, P., Nunez, O., Weinstein, B., Scheinberg, P., Biancotto, A., Wu, C. O., & Young, N. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103975 · Cited by 504
Self-citationHow I treat acquired aplastic anemia
Scheinberg, P., & Young, N. S. (2012) · Blood · doi:10.1182/blood-2011-12-274019 · Cited by 443
Self-citation
Metadata
- Authors
- Rosenfeld, S., Kimball, J., Vining, D., & Young, N.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1995-06-01
- Volume
- 85
- Issue
- 11
- Pages
- 3058-3065
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W105676805
- Cited by
- 319
- References
- 13
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. https://app.cochat.ai/papers/10.1182/blood.v85.11.3058.bloodjournal85113058
- The paper
- Rosenfeld, S., Kimball, J., Vining, D., & Young, N. (1995). Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. https://doi.org/10.1182/blood.v85.11.3058.bloodjournal85113058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.